A new study finds that three existing drugs can force leukemia cells into necroptosis, activating a strong immune response.

The great unknown, the final frontier – death. It’s a topic shrouded in both fear and morbid curiosity, a universal ...

Gary Marcus argues today’s AI sounds smart but lacks real understanding, and says true progress needs human-like reasoning.

Neanderthals are usually seen as brutish and primitive, but research now suggests our ancestors kissed often - and even with ...

NVIDIA Corp. (NASDAQ: NVDA) released its third-quarter earnings report after Wednesday’s closing bell. The transcript from ...

BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded ...

Tagliatela College of Engineering Professors Kristine Horvat, Ph.D., and Nagasree Garapati, Ph.D., as well as Amna Al-Azdee ...

The chips will be built with special materials that move tiny charged particles, called ions, to send signals — similar to how the brain’s neurons communicate. Most chips today rely only on ...

A Critique of Hobbesian Premises through the Lenses of Game Theory and Evolutionary Biology The “state of war” proposed by ...

Researchers have identified a previously unknown “hook-like” domain in the tail of the kinesin-2 motor protein that explains how these molecular machines select the right cargo inside cells.